Related Experiment Video

Updated: May 10, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K

Correction: Role of Tumor Molecular Profiling With FoundationOne®CDx in Advanced Solid Tumors: A Single-Centre

Ana Maria Popa1,2, Mihaela Andreea Stejeroiu1, Cristian Iaciu1

  • 1Medical Oncology, Elias Emergency University Hospital, Bucharest, ROU.

Cureus
|February 17, 2025
PubMed

Insights

This study corrects a previously published article DOI. The correction ensures accurate citation and retrieval of scientific research for better accessibility.

Area of Science:

  • Bibliometrics
  • Scientific Publishing
  • Scholarly Communication

Context:

  • Accurate citation is crucial for scientific integrity.
  • Digital Object Identifiers (DOIs) are essential for locating research.
  • Corrections to published articles ensure data reliability.

Purpose:

  • To amend the Digital Object Identifier (DOI) for a specific scientific publication.
  • To ensure the correct linkage between the article and its metadata.
  • To maintain the accuracy of scientific literature databases.

Summary:

  • This entry serves as a correction notice for the article with DOI 10.7759/cureus.50709.
  • The correction ensures that the Digital Object Identifier (DOI) accurately points to the intended scientific work.
  • This facilitates proper referencing and retrieval of the research.

Impact:

  • Improves the discoverability and accessibility of scientific research.
  • Upholds the integrity of scholarly communication.
  • Ensures accurate tracking of scientific publications and their citations.

More Related Videos

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.3K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...